Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
21 03 2023
Historique:
pubmed: 18 3 2023
medline: 23 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

Background Although there is research on the impact of social determinants of health (SDOHs) on cardiovascular health, most existing evidence is based on individual SDOH components. We evaluated the impact of cumulative SDOH burden on cardiovascular risk factors, subclinical atherosclerosis, and incident cardiovascular disease events. Methods and Results We included 6479 participants from the MESA (Multi-Ethnic Study of Atherosclerosis). A weighted aggregate SDOH score representing the cumulative number of unfavorable SDOHs, identified from 14 components across 5 domains (economic stability, neighborhood and physical environment, community and social context, education, and health care system access) was calculated and divided into quartiles (quartile 4 being the least favorable). The impact of cumulative SDOH burden on cardiovascular risk factors (hypertension, diabetes, dyslipidemia, smoking, and obesity), systemic inflammation, subclinical atherosclerosis, and incident cardiovascular disease was evaluated. Increasing social disadvantage was associated with increased odds of all cardiovascular risk factors except dyslipidemia. Smoking was the risk factor most strongly associated with worse SDOH (odds ratio [OR], 2.67 for quartile 4 versus quartile 1 [95% CI, 2.13-3.34]). Participants within SDOH quartile 4 had 33% higher odds of increased high-sensitivity C-reactive protein (OR, 1.33 [95% CI, 1.11-1.60]) and 31% higher risk of all cardiovascular disease (hazard ratio, 1.31 [95% CI, 1.03-1.67]), yet no greater burden of subclinical atherosclerosis (OR, 1.01 [95% CI, 0.79-1.29]), when compared with those in quartile 1. Conclusions Increasing social disadvantage was associated with more prevalent cardiovascular risk factors, inflammation, and incident cardiovascular disease. These findings call for better identification of SDOHs in clinical practice and stronger measures to mitigate the higher SDOH burden among the socially disadvantaged to improve cardiovascular outcomes.

Identifiants

pubmed: 36926956
doi: 10.1161/JAHA.122.025581
pmc: PMC10111542
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e025581

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201500003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01 HC095159
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States

Références

Circ Cardiovasc Qual Outcomes. 2022 Jan;15(1):e007917
pubmed: 35041484
Am J Prev Cardiol. 2021 Aug 30;8:100251
pubmed: 34553187
J Am Heart Assoc. 2014 Sep 30;3(5):e001252
pubmed: 25271209
Stroke. 2014 Aug;45(8):2318-23
pubmed: 25013018
J Health Psychol. 1997 Jul;2(3):335-51
pubmed: 22013026
Am J Epidemiol. 2002 Nov 1;156(9):871-81
pubmed: 12397006
Sci Rep. 2017 Sep 28;7(1):12370
pubmed: 28959022
PLoS One. 2017 May 16;12(5):e0177151
pubmed: 28510579
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):143-53
pubmed: 26941417
JAMA. 2020 Apr 28;323(16):1553-1554
pubmed: 32242887
Am J Public Health. 2006 Feb;96(2):332-9
pubmed: 16380570
Arch Intern Med. 2007 Jan 22;167(2):174-81
pubmed: 17242319
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
AMIA Annu Symp Proc. 2018 Apr 16;2017:1547-1553
pubmed: 29854224
JAMA Netw Open. 2020 Jul 1;3(7):e209649
pubmed: 32639567
Circulation. 2005 Sep 13;112(11):1557-65
pubmed: 16144996
Eur J Cardiovasc Prev Rehabil. 2007 Aug;14(4):568-74
pubmed: 17667649
PLoS One. 2016 Nov 22;11(11):e0165651
pubmed: 27875557
Am J Epidemiol. 2017 Aug 15;186(4):445-455
pubmed: 28407040
Psychosom Med. 2007 Jul-Aug;69(6):529-36
pubmed: 17636146
Am J Psychiatry. 2010 May;167(5):580-8
pubmed: 20123914
J Am Coll Cardiol. 2019 Jul 30;74(4):526-535
pubmed: 31345427
Front Physiol. 2021 Jan 14;11:609614
pubmed: 33519515
J Health Econ. 2018 Jan;57:31-44
pubmed: 29179027
Can J Cardiol. 2010 Aug-Sep;26 Suppl C:8C-13C
pubmed: 20847985
Prev Med. 2015 Feb;71:12-9
pubmed: 25482420
Am J Manag Care. 2020 Oct 1;26(10):e312-e318
pubmed: 33094943
Circulation. 2015 Sep 1;132(9):873-98
pubmed: 26240271
J Am Coll Cardiol. 2019 Feb 19;73(6):727-732
pubmed: 30765039
J Am Heart Assoc. 2022 Jan 18;11(2):e022837
pubmed: 35014862
Am Heart J. 2006 Sep;152(3):593-8
pubmed: 16923436
BMC Public Health. 2013 Mar 28;13:285
pubmed: 23537334
Ann Intern Med. 2014 Oct 21;161(8):587-93
pubmed: 25155419
Mol Psychiatry. 2020 Sep;25(9):2189-2199
pubmed: 31628416
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
Health Educ Behav. 2015 Jun;42(3):370-9
pubmed: 25431228
Circulation. 2021 Oct 19;144(16):1272-1279
pubmed: 34662161
Am J Public Health. 2015 Jun;105(6):1181-8
pubmed: 25322309
Am J Public Health. 1992 Jun;82(6):816-20
pubmed: 1585961
Am J Hypertens. 2017 Jan;30(1):75-80
pubmed: 27585566
Nicotine Tob Res. 2015 Aug;17(8):892-7
pubmed: 25516538
Circulation. 2006 Jan 3;113(1):30-7
pubmed: 16365194
Radiology. 2005 Jan;234(1):35-43
pubmed: 15618373
J Am Heart Assoc. 2021 Feb;10(5):e019541
pubmed: 33596667
J Clin Exp Dent. 2017 Aug 1;9(8):e988-e994
pubmed: 28936289
Eur J Prev Cardiol. 2018 Nov;25(16):1756-1764
pubmed: 30095278
Psychosom Med. 2009 Sep;71(7):756-62
pubmed: 19661194
Prev Chronic Dis. 2019 Jun 13;16:E74
pubmed: 31198164
Annu Rev Sociol. 2010 Aug;36:349-370
pubmed: 21909182
Am J Clin Nutr. 2009 May;89(5):1307-14
pubmed: 19297456

Auteurs

Isaac Acquah (I)

Center for Outcomes Research Houston Methodist Houston TX.

Kobina Hagan (K)

Center for Outcomes Research Houston Methodist Houston TX.

Zulqarnain Javed (Z)

Division of Health Disparities and Equity Research Center for Outcomes Research, Houston Methodist Houston TX.

Mohamad B Taha (MB)

Division of Cardiovascular Prevention and Wellness Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Javier Valero-Elizondo (J)

Center for Outcomes Research Houston Methodist Houston TX.

Nwabunie Nwana (N)

Center for Outcomes Research Houston Methodist Houston TX.

Tamer Yahya (T)

Division of Cardiovascular Prevention and Wellness Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Garima Sharma (G)

Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD.

Martha Gulati (M)

Division of Cardiology University of Arizona (Phoenix) Phoenix AZ.

Aziz Hammoud (A)

Wake Forest School of Medicine Winston Salem NC.

Michael D Shapiro (MD)

Section of Cardiovascular Medicine Wake Forest School of Medicine Winston Salem NC.

Ron Blankstein (R)

Cardiovascular Imaging Program, Department of Medicine and Radiology Brigham and Women's Hospital Boston MA.

Michael J Blaha (MJ)

Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD.

Miguel Cainzos-Achirica (M)

Center for Outcomes Research Houston Methodist Houston TX.
Division of Cardiovascular Prevention and Wellness Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Khurram Nasir (K)

Center for Outcomes Research Houston Methodist Houston TX.
Division of Cardiovascular Prevention and Wellness Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH